Prevenotics, a AI medical diagnostic software company, excels in developing cutting-edge technology that not only enhances the accuracy of cancer diagnosis but also provides active assistance in identifying pre-cancerous risks, thereby enabling preventive diagnosis
We recognize the importance of protecting our planet. By leveraging AI technology to systematize precancerous diagnosis, we aim to reduce unnecessary biopsies, thereby minimizing medical waste and conserving resources. This approach not only protects the environment but also reduces health risks associated with invasive procedures.
GI cancer, particularly upper-GI cancer, poses a significant threat, with a 5-year survival rate of only 20-40% in the U.S. and Western regions.Our solution offers a new option for differentiated preventive management in high-risk groups, ensuring that the gastric cancer risk in specific races is not overlooked. We are committed to improving health equity and access to preventive care for all communities.
We uphold the highest standards of governance and ethical practices in all our operations. Our commitment to transparency, accountability, and integrity guides our efforts to make a positive impact on society and the environment. Prevenotics is proud to integrate ESG principles into our core mission, striving to create a healthier, more sustainable future for all.
